Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000069.xml
Download PDF
Semin Liver Dis 2019; 39(01): 001-012
DOI: 10.1055/s-0038-1676120
DOI: 10.1055/s-0038-1676120
Review Article
Malignant Vascular Tumors of the Liver in Adults
Further Information
Publication History
Publication Date:
07 December 2018 (online)
Abstract
Hepatic angiosarcoma and epithelioid hemangioendothelioma (EHE) might be clinically considered a spectrum since, although more frequently presenting indolent behavior, EHE occasionally evolves to high-grade neoplasms. However, in most circumstances, pathological and immunohistochemical patterns define this differential diagnosis. More recently, molecular pathways for angiosarcoma and for EHE from other organs and from soft tissue have been proved different, paving the way for future morpho-molecular assessment of their hepatic counterpart. The frequency of liver involvement by Kaposi sarcoma in HIV-infected patients is lower nowadays. Histological findings and immunostaining for HHV-8 Ag are characteristic. Hepatic small vessel neoplasms have been recently recognized as important mimickers of angiosarcoma. The criteria for this differential diagnosis and the clinical behavior, up to now considered favorable, must be further studied.
-
References
- 1 Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006; 54 (04) 385-395
- 2 Miettinen M. Immunohistochemistry of soft tissue tumours: review with emphasis on 10 markers. Histopathology 2014; 64 (01) 101-118
- 3 den Bakker MA, Flood SJ, Kliffen M. CD31 staining in epithelioid sarcoma. Virchows Arch 2003; 443 (01) 93-97
- 4 Nicholson SA, McDermott MB, DeYoung BR, Swanson PE. CD31 immunoreactivity in small round cell tumors. Appl Immunohistochem Mol Morphol 2000; 8 (01) 19-24
- 5 Sebenik M, Ricci Jr A, DiPasquale B. , et al. Undifferentiated intimal sarcoma of large systemic blood vessels: report of 14 cases with immunohistochemical profile and review of the literature. Am J Surg Pathol 2005; 29 (09) 1184-1193
- 6 De Young BR, Frierson Jr HF, Ly MN, Smith D, Swanson PE. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol 1998; 110 (03) 374-377
- 7 Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells 2014; 32 (06) 1380-1389
- 8 Natkunam Y, Rouse RV, Zhu S, Fisher C, van De Rijn M. Immunoblot analysis of CD34 expression in histologically diverse neoplasms. Am J Pathol 2000; 156 (01) 21-27
- 9 Shidham VB, Chivukula M, Gupta D, Rao RN, Komorowski R. Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch Pathol Lab Med 2002; 126 (10) 1189-1192
- 10 Folpe AL, Chand EM, Goldblum JR, Weiss SW. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol 2001; 25 (08) 1061-1066
- 11 Lee AF, Hayes MM, Lebrun D. , et al. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma. Appl Immunohistochem Mol Morphol 2011; 19 (03) 233-238
- 12 Miettinen M, Wang ZF, Paetau A. , et al. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol 2011; 35 (03) 432-441
- 13 Wang WL, Patel NR, Caragea M. , et al. Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma. Mod Pathol 2012; 25 (10) 1378-1383
- 14 Perner S, Mosquera JM, Demichelis F. , et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007; 31 (06) 882-888
- 15 Ordóñez NG. Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update. Appl Immunohistochem Mol Morphol 2014; 22 (05) 331-347
- 16 Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 2005; 46 (04) 396-402
- 17 Naqvi J, Ordóñez NG, Luna MA, Williams MD, Weber RS, El-Naggar AK. Epithelioid hemangioendothelioma of the head and neck: role of podoplanin in the differential diagnosis. Head Neck Pathol 2008; 2 (01) 25-30
- 18 Fujii T, Zen Y, Sato Y. , et al. Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver. Mod Pathol 2008; 21 (02) 125-130
- 19 Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 2002; 15 (04) 434-440
- 20 Xu H, Edwards JR, Espinosa O, Banerji S, Jackson DG, Athanasou NA. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum Pathol 2004; 35 (07) 857-861
- 21 Miettinen M, Wang ZF. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Am J Surg Pathol 2012; 36 (03) 351-359
- 22 Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol 2008; 129 (06) 705-733
- 23 Thomas LB, Popper H. Pathology of angiosarcoma of the liver among vinyl chloride-polyvinyl chloride workers. Ann N Y Acad Sci 1975; 246: 268-277
- 24 Groeschl RT, Miura JT, Oshima K, Gamblin TC, Turaga KK. Does histology predict outcome for malignant vascular tumors of the liver?. J Surg Oncol 2014; 109 (05) 483-486
- 25 Bolt HM. Vinyl chloride: a classical industrial toxicant of new interest. Crit Rev Toxicol 2005; 35 (04) 307-323
- 26 Weihrauch M, Bader M, Lehnert G. , et al. Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride. Environ Mol Mutagen 2002; 40 (01) 36-40
- 27 Hollstein M, Marion MJ, Lehman T. , et al. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis 1994; 15 (01) 1-3
- 28 Kielhorn J, Melber C, Wahnschaffe U, Aitio A, Mangelsdorf I. Vinyl chloride: still a cause for concern. Environ Health Perspect 2000; 108 (07) 579-588
- 29 Zheng YW, Zhang XW, Zhang JL. , et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol 2014; 29 (05) 906-911
- 30 Pickhardt PJ, Kitchin D, Lubner MG, Ganeshan DM, Bhalla S, Covey AM. Primary hepatic angiosarcoma: multi-institutional comprehensive cancer centre review of multiphasic CT and MR imaging in 35 patients. Eur Radiol 2015; 25 (02) 315-322
- 31 Ferrell LD, Kakar SK, Wee A, Terracciano LM. Tumours and tumour-like lesions of the liver. In: Burt AD, Ferrell LD, Hübscher S. , eds. MacSween's Pathology of the Liver. 7th ed. New York: Elsevier; 2018: 780-879
- 32 Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 1998; 22 (06) 683-697
- 33 Botros M, Quevedo JF, Miller RC. Angiosarcoma of the liver after multimodality therapy for gallbladder carcinoma. Radiol Oncol 2009; 43: 126-131
- 34 Dogan A, Kern P, Schultheis B, Häusler G, Rezniczek GA, Tempfer CB. Radiogenic angiosarcoma of the breast: case report and systematic review of the literature. BMC Cancer 2018; 18 (01) 463-474
- 35 Cornejo KM, Deng A, Wu H. , et al. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast. Hum Pathol 2015; 46 (06) 868-875
- 36
Prenen H,
Smeets D,
Mazzone M.
, et al. Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under
targeted therapy in a patient with hepatic angiosarcoma. Oncotarget 2015; 6 (34) 36418-36425
MissingFormLabel
- 37 Huang SC, Zhang L, Sung YS. , et al. Recurrent CIC gene abnormalities in angiosarcomas: a molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations. Am J Surg Pathol 2016; 40 (05) 645-655
- 38 Dang CV. MYC on the path to cancer. Cell 2012; 149 (01) 22-35
- 39 Manner J, Radlwimmer B, Hohenberger P. , et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 2010; 176 (01) 34-39
- 40 Käcker C, Marx A, Mössinger K. , et al. High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas: further results from EORTC STBSG TL 01/01. Genes Chromosomes Cancer 2013; 52 (01) 93-98
- 41 Guo T, Zhang L, Chang NE, Singer S, Maki RG, Antonescu CR. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Genes Chromosomes Cancer 2011; 50 (01) 25-33
- 42 Shon W, Sukov WR, Jenkins SM, Folpe AL. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study. Mod Pathol 2014; 27 (04) 509-515
- 43 Dissanayake K, Toth R, Blakey J. , et al. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa. Biochem J 2011; 433 (03) 515-525
- 44 Bettegowda C, Agrawal N, Jiao Y. , et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 2011; 333 (6048): 1453-1455
- 45 Italiano A, Sung YS, Zhang L. , et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer 2012; 51 (03) 207-218
- 46 Vaqué JP, Gómez-López G, Monsálvez V. , et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood 2014; 123 (13) 2034-2043
- 47 Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2011; 2 (12) 1097-1105
- 48 Ray-Coquard I, Italiano A, Bompas E. , et al; French Sarcoma Group (GSF/GETO). Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO). Oncologist 2012; 17 (02) 260-266
- 49 Italiano A, Thomas R, Breen M. , et al. The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification. Genes Chromosomes Cancer 2012; 51 (06) 569-578
- 50 Italiano A, Chen CL, Thomas R. , et al. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics. Cancer 2012; 118 (23) 5878-5887
- 51 Rossi S, Fletcher CD. Angiosarcoma arising in hemangioma/vascular malformation: report of four cases and review of the literature. Am J Surg Pathol 2002; 26 (10) 1319-1329
- 52 Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss's Soft Tissue Tumors. 6th ed. Philadelphia, PA: Saunders/Elsevier; 2014: 1155
- 53 Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 1999; 85 (03) 562-582
- 54 Torres LR, Timbó LS, Ribeiro CM, Galvão Filho MM, Verrastro CG, D'Ippolito G. Multifocal and metastatic hepatic hemangioendothelioma: case report and literature review. Radiol Bras 2014; 47 (03) 194-196
- 55 Hayashi Y, Inagaki K, Hirota S, Yoshikawa T, Ikawa H. Epithelioid hemangioendothelioma with marked liver deformity and secondary Budd-Chiari syndrome: pathological and radiological correlation. Pathol Int 1999; 49 (06) 547-552
- 56 Mehrabi A, Kashfi A, Fonouni H. , et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 2006; 107 (09) 2108-2121
- 57 Remiszewski P, Szczerba E, Kalinowski P. , et al. Epithelioid hemangioendothelioma of the liver as a rare indication for liver transplantation. World J Gastroenterol 2014; 20 (32) 11333-11339
- 58 Bruegel M, Muenzel D, Waldt S, Specht K, Rummeny EJ. Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging. Abdom Imaging 2011; 36 (04) 415-424
- 59 Harman M, Nart D, Acar T, Elmas N. Primary mesenchymal liver tumors: radiological spectrum, differential diagnosis, and pathologic correlation. Abdom Imaging 2015; 40 (05) 1316-1330
- 60 Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982; 50 (05) 970-981
- 61 Ressurreição J, Matos C, Bali M. Rapid progression of multifocal hepatic epithelioid hemangioendothelioma. GE Port J Gastroenterol 2015; 22 (03) 123-125
- 62 Antonescu CR, Le Loarer F, Mosquera J-M. , et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 2013; 52 (08) 775-784
- 63 Flucke U, Vogels RJ, de Saint Aubain Somerhausen N. , et al. Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagn Pathol 2014; 9: 131-142
- 64 Deyrup AT, Tighiouart M, Montag AG, Weiss SW. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol 2008; 32 (06) 924-927
- 65 Errani C, Zhang L, Sung YS. , et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 2011; 50 (08) 644-653
- 66 Shibuya R, Matsuyama A, Shiba E, Harada H, Yabuki K, Hisaoka M. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Histopathology 2015; 67 (06) 827-835
- 67 Kuo FY, Huang HY, Chen CL, Eng HL, Huang CC. TFE3-rearranged hepatic epithelioid hemangioendothelioma: a case report with immunohistochemical and molecular study. APMIS 2017; 125 (09) 849-853
- 68 Mahale P, Engels EA, Coghill AE, Kahn AR, Shiels MS. Cancer risk in older people living with human immunodeficiency virus infection in the United States. Clin Infect Dis 2018; 67 (01) 50-57
- 69 Chen F, Gulati M, Tchelepi H. Hepatic Kaposi sarcoma revisited: an important but less commonly seen neoplasm in patients with acquired immunodeficiency syndrome. Ultrasound Q 2017; 33 (01) 109-111
- 70 Van Leer-Greenberg B, Kole A, Chawla S. Hepatic Kaposi sarcoma: a case report and review of the literature. World J Hepatol 2017; 9 (04) 171-179
- 71 Sharma S, Gurakar A, Camci C, Jabbour N. Avoiding pitfalls: what an endoscopist should know in liver transplantation—part II. Dig Dis Sci 2009; 54 (07) 1386-1402
- 72 Gore RM, Miller FH, Yaghmai V. Acquired immunodeficiency syndrome (AIDS) of the abdominal organs: imaging features. Semin Ultrasound CT MR 1998; 19 (02) 175-189
- 73 Restrepo CS, Martínez S, Lemos JA. , et al. Imaging manifestations of Kaposi sarcoma. Radiographics 2006; 26 (04) 1169-1185
- 74 Duarte MIS, Duarte Neto A. Human immunodeficiency virus infection of the liver. In: Saxena R. , ed. Practical Hepatic Pathology: A Diagnostic Approach. 2nd ed. New York, NY: Elsevier; 2018: 247-264
- 75 Zeng Y, Zhang X, Huang Z. , et al. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol 2007; 81 (05) 2401-2417
- 76 Russo JJ, Bohenzky RA, Chien MC. , et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 1996; 93 (25) 14862-14867
- 77 Dahlke C, Maul K, Christalla T. , et al. A microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo. PLoS One 2012; 7 (11) e49435
- 78 Noda T, Sasaki Y, Yamada T. , et al. Adult capillary hemangioma of the liver: report of a case. Surg Today 2005; 35 (09) 796-799
- 79 Lewis S, Aljarallah B, Trivedi A, Thung SN. Magnetic resonance imaging of a small vessel hepatic hemangioma in a cirrhotic patient with histopathologic correlation. Clin Imaging 2015; 39 (04) 702-706
- 80 Rangaswamy B, Minervini M, Tublin M, Sholosh B, Dasyam AK. Imaging and pathologic findings of hepatic small vessel hemangioma. Curr Probl Diagn Radiol 2018(e-pub ahead of print). Doi: 10.1067/j.cpradiol.2018.02.006
- 81 Gill RM, Buelow B, Mather C. , et al. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Hum Pathol 2016; 54: 143-151
- 82 Walcott-Sapp S, Tang E, Kakar S, Shen J, Hansen P. Resection of the largest reported hepatic small vessel neoplasm. Hum Pathol 2018; 78: 159-162